Recruited to support the start-up of a new biotechnology company formed from the merger of a division of Baxter International [Hyland] and an Austrian vaccines company [Immuno AG]. Responsible for M&A support and implementation of new HRD systems. Worked in multiple locations, primarily U.S., Austria, Switzerland, and the Czech Republic.
§Co-facilitated the senior leadership team start-up of new biotech business. Provided support for business strategy development and execution, as well as the formulation of the core mission, vision, and long term objectives. Provided executive coaching, team building and facilitation to the key executive teams improving performance and business results.
§Led integration/change management activities for multiple global business acquisitions, and provided design and strategy support for the development of Baxter Healthcare’s corporate M&Amodel, improving the speed and quality of integration.
§Facilitated the re-start of the number one priority product development project for Baxter Healthcare, accelerating market delivery from 2 years behind schedule to 6 months early, with a projected revenue opportunity in excess of $1B.
§Designed and implemented a manufacturing improvement strategy to reduce the cycle time from manufacture to fill/finish on biopharmaceutical products manufactured in Europe [Austria, Switzerland, and the Czech Republic]. Cycle time was reduced from 150 days to 29 days in less than 3 months, with a multi-million dollar savings in inventory carrying costs. The project served as a platform for the implementation of 6Sigma.
§Initiated and co-led a cross-divisional, global change initiative that built project management and product development capability across Baxter Healthcare, leading to improvements in drug development delivery and profitability.